Literature DB >> 15473339

Uterine body cancer mass screening at Tokai University Hospital.

Eri Nagase1, Masanori Yasuda, Hiroshi Kajiwara, R Yoshiyuki Osamura, Tomoko Yoshitake, Takeshi Hirasawa, Toshinari Muramatsu, Tsuyoshi Miyamoto, Masaru Murakami, Tsunehisa Makino, Teppei Ogawa.   

Abstract

A total of 1,512 women participated in mass screenings for uterine body cancer (UBC) from 1998 to 2003 at Tokai University Hospital. Their rate in the examinees of uterine cervical cancer (UCC) mass screenings was 4.7%. Among the 1,512 examinees, endometrial cytological abnormalities (class III or higher) were found in 17 (1.1%) cases. As a result, UBC was detected in two patients (0.13%). One case was diagnosed as class V, adenocarcinoma, and she underwent hysterectomy. In another case, adenocarcinoma was found to be associated with atypical endometrial hyperplasia in hysterectomy specimens. For the remaining 15 cases diagnosed as class III, the cytological abnormalities disappeared after a follow-up except for 3 patients who were not followed at Tokai University Hospital. In a comparison of the examinees with or without genital bleeding, the cytological abnormalities were more frequently detected in the former group; 4.2% (6/142) vs. 0.6% (5/819) (p < 0.05). We recommend examinees aged 40 years or higher with a complaint of genital bleeding to participate in UBC mass screening for detection of endometrial adenocarcinoma at early stages.

Entities:  

Mesh:

Year:  2004        PMID: 15473339

Source DB:  PubMed          Journal:  Tokai J Exp Clin Med        ISSN: 0385-0005


  2 in total

1.  Endometrial Cytology as a Method to Improve the Accuracy of Diagnosis of Endometrial Cancer: Case Report and Meta-Analysis.

Authors:  Qing Wang; Qi Wang; Lanbo Zhao; Lu Han; Chao Sun; Sijia Ma; Huilian Hou; Qing Song; Qiling Li
Journal:  Front Oncol       Date:  2019-04-24       Impact factor: 6.244

2.  Diagnostic accuracy of cytology for the detection of endometrial cancer in urine and vaginal samples.

Authors:  Helena O'Flynn; Neil A J Ryan; Nadira Narine; David Shelton; Durgesh Rana; Emma J Crosbie
Journal:  Nat Commun       Date:  2021-02-11       Impact factor: 14.919

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.